I was honored to be invited by USAID (Dr. Amar Shah) and the WHO (Dr. Malik Parmar) to serve as Mewat Evaluation Team Leader for India’s Evaluation of Integrated Digital Adherence Technology (IDAT) For Treatment Support of TB Patients. Our team [Mr. Bruce Thomas (lead), Dr. Shanker Matta, Mr. Bharat Bhushan Dahiya, Dr. Bhavin Vadera, Dr. Srikrishna S R, Dr. Yogesh Gurav, Dr. […]
Evaluation Team Lead for IDAT for Treatment Support of TB Patients
Stop TB Award
We are honored and thrilled that the Stop TB Partnership’s Strategic Initiatives and Innovative Financing (“SIIF”) team has selected The Arcady Group to provide consulting services to accelerate the roll-out of emerging technologies and digital health solutions to End TB.
More adherence support for self-administering TB patients is on the way!
Unitaid and the KNCV Tuberculosis Foundation signed a US$13.9 million grant agreement to enhance the existing evidence base, drive scaled deployment, and create market access plans and tools for digital adherence technologies to enhance TB medication adherence.
VIDEO: Peter Small’s #RockyTalk on Patient-Centered TB Medication Adherence
Peter Small, has led the call for more patient-centered ways of assisting TB patients with treatment adherence. In this video, published by the Rockefeller Foundation, Peter shares how emerging technologies can make it easier for patients.
CONFERENCE PRESENTATION: Finally! New, Patient-Centered Models Of Care For TB Patients In High Burden Regions
Earlier this year, Arcady Founder, Bruce Thomas presented at the HealthXL Global Gathering in Melbourne, Australia. HealthXL Global Gatherings showcase innovation on a global platform by bringing together people with ideas, resources and desire to contribute to the evolution of healthcare. This year’s event assembled leaders and innovators of the world’s most disruptive health technology […]
Publication: Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China – study protocol for a cluster randomised controlled trial
Over the past several years, a number of studies have been published demonstrating the feasibility, acceptability, and adherence enhancing impact of medication adherence monitoring technologies on TB medication adherence in high-burden regions. However, none of these studies have evaluated health outcomes as a primary endpoint. Bruce Thomas, Arcady Founder, is a contributing author for recently […]
PRESS RELEASE: The Arcady Group Awarded Grant to Continue Activities to Improve TB Medication Adherence and Treatment Outcomes for Patients in High TB Burden Regions
The Arcady Group, LLC, a consulting company that works to enhance patient and disease management by addressing the challenges of medication non-adherence, has been awarded a grant from the Bill & Melinda Gates Foundation to continue Arcady’s activities to improve TB medication adherence and TB treatment outcomes. Under this most recent grant, the third from […]
